{"DataElement":{"publicId":"5778785","version":"1","preferredName":"Patient Prior Therapy Performed Imaging Requirement And No Imaging Evidence Progressive Disease Clinical Trial Eligibility Criteria Code Indicator","preferredDefinition":"A coded response to questions which are necessary to allow a person to participate in a clinical study that are related to prior treatments, requirements for imaging procedures that were performed, and no imaging evidence of disease progression.","longName":"PRTX_NO_IMG_DZEV","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"5778780","version":"1","preferredName":"Patient Prior Therapeutic Procedure Performed Imaging Requirement Negation Imaging Technique Evidence Progressive Disease Clinical Trial Eligibility Criteria","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Earlier in time or order._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The completed action of obtaining pictures of the interior or exterior of the body usually for diagnostic reasons._Something that is a necessary condition; something that is obligatory._An operation in which a term denies or inverts the meaning of another term or construction._Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy._Knowledge on which to base belief._A disease process that is increasing in scope or severity._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2233604v1.0:5778788v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5778788","version":"1","preferredName":"Prior Therapeutic Procedure Performed Imaging Requirement Negation Imaging Technique Evidence Progressive Disease Clinical Trial Eligibility Criteria","preferredDefinition":"Earlier in time or order.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:The completed action of obtaining pictures of the interior or exterior of the body usually for diagnostic reasons.:Something that is a necessary condition; something that is obligatory.:An operation in which a term denies or inverts the meaning of another term or construction.:Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.:Knowledge on which to base belief.:A disease process that is increasing in scope or severity.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"5778788v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"8"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Performed Imaging","conceptCode":"C93428","definition":"The completed action of obtaining pictures of the interior or exterior of the body usually for diagnostic reasons.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Imaging Technique","conceptCode":"C17369","definition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Evidence","conceptCode":"C43583","definition":"Knowledge on which to base belief.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DB2CBFB-E145-097C-E053-F662850A94D9","latestVersionIndicator":"Yes","beginDate":"2017-04-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-04-21","modifiedBy":"ONEDATA","dateModified":"2017-04-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DB35298-03ED-1839-E053-F662850AC3D0","latestVersionIndicator":"Yes","beginDate":"2017-04-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-04-21","modifiedBy":"SOKKERL","dateModified":"2020-03-26","changeDescription":"11/8/18 TT released/PClark. 10021 4/21/2017 Ls/TT","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3298541","version":"1","preferredName":"Yes No Not Applicable Code Indicator","preferredDefinition":"Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.","longName":"YES_NO_NA_CD_IND","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"X","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C223-0627-E040-BB89AD432C31","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"},{"value":"N","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C22D-0627-E040-BB89AD432C31","beginDate":"2002-08-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"},{"value":"Y","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C237-0627-E040-BB89AD432C31","beginDate":"2002-08-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3298540","version":"1","preferredName":"Yes No Not Applicable Code Indicator","preferredDefinition":"The affirmative response to a question or activity.:The non-affirmative response to a question.:Determination that a value is not relevant in the current context.:A system of numbered categories for representation of data.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3298540v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C1F2-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTMS:Clinical Trials Monitoring Service","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C203-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"MAESKEB","dateModified":"2016-01-20","changeDescription":"Created to support Theradex design of CRFs for NCI CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3876352","version":"1","longName":"Inclusion Criteria","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876426","version":"1","longName":"Physical & Concomitant Requirements","context":"Theradex"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"If patient has brain metastas","type":"Preferred Question Text","description":"If patient has brain metastases that has been treated, have the imaging scans been obtained at least four weeks apart and show no evidence of intracranial progression?","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"If patient is registered to the safety-run in portion of the study and has a history of brain metastases, there is no disease progression symptomatically and by imaging within 28 days prior to registration and patient is off steroids?","url":null,"context":"Theradex"},{"name":"Theradex - 3","type":"Alternate Question Text","description":"If patient has a history of brain metastases, patient is not on steroid therapy and there is no evidence of intracranial disease progression symptomatically or by imaging within 28 days prior to study registration?","url":null,"context":"Theradex"},{"name":"Theradex - 2","type":"Alternate Question Text","description":"If patient has brain metastases, have metastases been treated and there is no MRI evidence of progression for 4 weeks after treatment is complete and no evidence of progression within 28 days prior to study entry?","url":null,"context":"Theradex"},{"name":"Theradex - 4","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression for 4 weeks?","url":null,"context":"Theradex"},{"name":"Theradex - 7","type":"Alternate Question Text","description":"If patient has treated brain metastases, if there is no evidence of progression for at least 4 weeks after CNS-directed treatment, as ascertained by clinical examination and brain imaging (MRI or CT) during the screening period?","url":null,"context":"Theradex"},{"name":"Theradex - 5","type":"Alternate Question Text","description":"If patient has treated brain metastases, have the metastases been radiographically and clinically stable for at least one month and if patient is on steroids for this indication, the patient must be on a stable dose for at least one month?","url":null,"context":"Theradex"},{"name":"Theradex - 6","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression?","url":null,"context":"Theradex"},{"name":"Theradex - 9","type":"Alternate Question Text","description":"If patient has a history of treated brain metastases, does follow-up brain imaging 30 days after central nervous system (CNS)-directed therapy show no evidence of progression?","url":null,"context":"Theradex"},{"name":"Theradex - 8","type":"Alternate Question Text","description":"If patient has asymptomatic, treated brain metastases, there is no evidence of progression for at least 4 weeks after central nervous system (CNS)-directed treatment, as ascertained by clinical examination and brain imaging (magnetic resonance imaging [MRI] or CT scan) during the screening period?","url":null,"context":"Theradex"},{"name":"Theradex - 10","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression, patient is off steroids and is clinically stable?","url":null,"context":"Theradex"},{"name":"Theradex - 14","type":"Alternate Question Text","description":"If patient has previously treated brain metastases, are they stable (without evidence of progression by imaging for at least four weeks prior to the first dose of protocol treatment and any neurologic symptoms have returned to baseline), have no evidence of new or enlarging brain metastases, and are not using steroids for at least 7 days prior to protocol treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 11","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression within 28 days?","url":null,"context":"Theradex"},{"name":"Theradex - 12","type":"Alternate Question Text","description":"If patient has previously treated brain metastases, are they are stable (without evidence of progression by imaging for at least four weeks prior to the first dose of protocol treatment and any neurologic symptoms have returned to baseline), have no evidence of new or enlarging brain metastases, and are not using steroids for at least 7 days prior to protocol treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 13","type":"Alternate Question Text","description":"If patient has treated stable brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression and patient is off corticosteroids for brain metastases?","url":null,"context":"Theradex"},{"name":"Theradex - 15","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression for greater than or equal to 1 month after treatment of the brain metastases?","url":null,"context":"Theradex"},{"name":"Theradex - 16","type":"Alternate Question Text","description":"If patient has treated brain metastases, there is no evidence of progression for at least 4 weeks after CNS-directed treatment, as ascertained by clinical examination and brain imaging (MRI or CT) during the screening period?","url":null,"context":"Theradex"},{"name":"Theradex - 21","type":"Alternate Question Text","description":"If patient has treated brain metastases, or primary brain tumors,  does the follow-up brain imaging after central nervous system (CNS)- directed therapy reveal no evidence of progression for greater than or equal to 4 weeks after the last dose of treatment and are not taking corticosteroids for at least 4 weeks prior to beginning the protocol?","url":null,"context":"Theradex"},{"name":"Theradex - 18","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression for a minimum of 3 months?","url":null,"context":"Theradex"},{"name":"Theradex - 17","type":"Alternate Question Text","description":"If patient has treated brain metastases does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression and patient is asymptomatic from previously treated brain metastases (e.g. not on steroids for neurologic symptoms within 30 days of study enrollment)?","url":null,"context":"Theradex"},{"name":"Theradex - 19","type":"Alternate Question Text","description":"If patient has previously treated brain metastases, are they stable (without evidence of progression by imaging using the identical imaging modality for each assessment, either magnetic resonance imaging [MRI] or computed tomography [CT] scan, for at least 4 weeks prior to the first dose of trial treatment and any neurologic symptoms have returned to baseline), and there is no evidence of new or enlarging brain metastases, and patient is not using steroids for at least 7 days prior to trial treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 20","type":"Alternate Question Text","description":"If patient has symptomatic CNS metastases, does previous treatment with surgery and/or radiation show no evidence of radiologic CNS recurrence or progression for 4 weeks and is patient on stable/tapering dose of steroid for at least one week prior to start of study drug?","url":null,"context":"Theradex"},{"name":"Theradex - 22","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression/recurrence for greater than or equal to 3 months and the patient no longer requires more than a physiologic dose of steroids?","url":null,"context":"Theradex"},{"name":"Theradex - 23","type":"Alternate Question Text","description":"If patient has treated brain metastases, follow-up brain imaging done at least 4 weeks after central nervous system (CNS)-directed therapy shows no evidence of progression?","url":null,"context":"Theradex"},{"name":"Theradex - 24","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging done at least 4 weeks after central nervous system (CNS)-directed therapy shows no evidence of progression and the patient no longer requires steroids, or is on a stable steroid dose greater than 4 weeks?","url":null,"context":"Theradex"},{"name":"Theradex - 25","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression and patient is clinically stable for at least 1 month?","url":null,"context":"Theradex"},{"name":"Theradex - 26","type":"Alternate Question Text","description":"If patient has treated brain metastases, follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression, stable and off steroids for 1 month?","url":null,"context":"Theradex"},{"name":"Theradex - 27","type":"Alternate Question Text","description":"If patient has treated brain metastases, follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression as determined by a repeat imaging study at least 4 weeks following the completion of treatment and patient has been stable off steroids for at least 1 month?","url":null,"context":"Theradex"},{"name":"Theradex - 28","type":"Alternate Question Text","description":"If patient has treated brain metastases, is there evidence of measurable extracranial disease, and follow-up brain imaging 4 weeks after central nervous system (CNS)-direct therapy shows no evidence of progression?","url":null,"context":"Theradex"},{"name":"Theradex - 29","type":"Alternate Question Text","description":"If patient has treated brain metastases and is off steroids, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression for at least 4 weeks prior to enrollment in the study?","url":null,"context":"Theradex"},{"name":"Theradex - 30","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of progression by scan and is stable off systemic steroids for at least 4 weeks?","url":null,"context":"Theradex"},{"name":"Theradex - 31","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression while off steroid support?","url":null,"context":"Theradex"},{"name":"Theradex - 32","type":"Alternate Question Text","description":"If patient has treated brain metastases, follow-up brain imaging done after central nervous system (CNS)-directed therapy shows no evidence of progression for greater than or equal to 1 month after treatment of the brain metastases?","url":null,"context":"Theradex"},{"name":"Theradex - 33","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging done after central nervous system (CNS)-directed therapy shows no evidence of progression for greater than or equal to 1 month after treatment of the brain metastases?","url":null,"context":"Theradex"},{"name":"Theradex - 34","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging 6-8 weeks after central nervous system (CNS)-directed therapy show no evidence of progression or CNS lymphoma?","url":null,"context":"Theradex"},{"name":"NRG Text_1","type":"Alternate Question Text","description":"Does follow up brain imaging after CNS directed therapy show no evidence of progression for 3 months or more, patient is not on steroids and asymptomatic?","url":null,"context":"NRG"},{"name":"Theradex - 35","type":"Alternate Question Text","description":"If patient has treated brain metastases, does follow-up brain imaging performed within 10 days after central nervous system (CNS)-directed therapy show no evidence of progression?","url":null,"context":"Theradex"},{"name":"Theradex - 36","type":"Alternate Question Text","description":"If patient has had treated brain metastases, does follow-up brain imaging after central nervous system (CNS)-directed therapy show no evidence of progression?","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DB35298-0413-1839-E053-F662850AC3D0","latestVersionIndicator":"Yes","beginDate":"2017-04-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-04-21","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":"11/8/18 TT released/PClark. 10021 4/21/2017 LS/TT","administrativeNotes":"10.22.2023_Added AQT per ticket request CADSR0002989_mmt","unresolvedIssues":null,"deletedIndicator":"No"}}